SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 151 filers reported holding SAGE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,865,000 | -72.4% | 53,539 | -46.4% | 0.28% | -73.1% |
| Q3 2019 | $14,011,000 | -27.8% | 99,868 | -5.7% | 1.05% | -21.4% |
| Q2 2019 | $19,398,000 | +1.0% | 105,945 | -12.2% | 1.34% | +9.8% |
| Q1 2019 | $19,197,000 | -13.4% | 120,695 | -47.9% | 1.22% | -23.5% |
| Q4 2018 | $22,174,000 | -34.9% | 231,483 | -4.0% | 1.60% | -15.1% |
| Q3 2018 | $34,055,000 | -16.3% | 241,099 | -7.2% | 1.88% | -18.4% |
| Q2 2018 | $40,671,000 | -9.7% | 259,828 | -7.1% | 2.30% | -7.8% |
| Q1 2018 | $45,045,000 | -21.1% | 279,659 | -19.3% | 2.50% | -8.3% |
| Q4 2017 | $57,088,000 | +24.4% | 346,597 | -53.0% | 2.72% | +46.1% |
| Q3 2017 | $45,897,000 | -21.0% | 736,709 | +0.9% | 1.86% | +0.6% |
| Q2 2017 | $58,127,000 | -0.4% | 729,874 | -11.1% | 1.85% | -5.4% |
| Q1 2017 | $58,353,000 | +12.6% | 821,070 | -19.1% | 1.96% | +16.7% |
| Q4 2016 | $51,802,000 | -2.6% | 1,014,527 | -12.1% | 1.68% | +21.7% |
| Q3 2016 | $53,164,000 | +176.0% | 1,154,481 | +80.6% | 1.38% | +178.8% |
| Q2 2016 | $19,262,000 | -54.0% | 639,301 | -51.1% | 0.50% | -8.0% |
| Q1 2016 | $41,880,000 | +10.3% | 1,306,306 | +100.5% | 0.54% | -40.9% |
| Q4 2015 | $37,977,000 | +35.9% | 651,420 | -1.3% | 0.91% | +36.6% |
| Q3 2015 | $27,940,000 | -42.1% | 660,218 | -0.1% | 0.67% | -35.0% |
| Q2 2015 | $48,245,000 | +149.0% | 660,895 | +71.3% | 1.02% | +135.9% |
| Q1 2015 | $19,377,000 | – | 385,770 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |